Craig Crosson to Ocular Hypertension
This is a "connection" page, showing publications Craig Crosson has written about Ocular Hypertension.
Connection Strength
2.882
-
Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia. Exp Eye Res. 2022 11; 224:109250.
Score: 0.782
-
Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension. Invest Ophthalmol Vis Sci. 2014 Oct 30; 55(11):7486-93.
Score: 0.453
-
FR-190997, a nonpeptide bradykinin B2-receptor partial agonist, is a potent and efficacious intraocular pressure lowering agent in ocular hypertensive cynomolgus monkeys. Drug Dev Res. 2014 Jun; 75(4):211-23.
Score: 0.437
-
Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model. Invest Ophthalmol Vis Sci. 2012 Jun 28; 53(7):4289-98.
Score: 0.385
-
Intraocular adenosine levels in normal and ocular-hypertensive patients. J Ocul Pharmacol Ther. 2003 Apr; 19(2):113-9.
Score: 0.203
-
Evidence for ceramide induced cytotoxicity in retinal ganglion cells. Exp Eye Res. 2021 10; 211:108762.
Score: 0.182
-
Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. J Glaucoma. 1999 Aug; 8(4):257-62.
Score: 0.157
-
Characterization of ocular hypertension induced by adenosine agonists. Invest Ophthalmol Vis Sci. 1996 Aug; 37(9):1833-9.
Score: 0.128
-
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma. J Med Chem. 2009 Nov 12; 52(21):6515-8.
Score: 0.080
-
Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes. Exp Eye Res. 2009 Mar; 88(3):386-97.
Score: 0.075